Back to Screener

Basic Materials

Novozymes A/S(NVZMF)

Live Price

Offline

$60.00

-4.12% today

1Y Change

-11.04%

Window

Jun 30, 2025 โ†’ Jun 24, 2026

Market Cap
$24.92B
Revenue Growth
-85.5%
EPS Growth
+86.6%
Dividend Yield
1.6%

Coverage: 247 bars ยท Jun 30, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Novozymes A/S (NVZMF) is a Basic Materials stock with a market cap of $24.92B and listed on OTC. The stock last traded around $60.00 and down 11.0% across the available one-year price window (Jun 30, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of -85.5%, EPS growth of +86.6%, a dividend yield of 1.6%. What stands out right now is revenue -85.5%, EPS +86.6%, free cash flow +13.7% with operating margin 21.2% and ROIC 2.6%. The dividend is present but secondary, with a yield around 1.6%. Valuation already assumes a fairly strong business story at P/E 38.0 and price/sales 6.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines NVZMF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Basic Materials peers on this page.

Benchmark Edge

NVZMF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

NVZMF trails SPY

NVZMF is 29.72 pts behind over the shared 1Y window.

NVZMF had 18.25 pts deeper max drawdown than SPY.

NVZMF beat SPY in 0 of 2 calendar years shown and trailed in 2.

NVZMF

-11.04%

Normalized return

SPY

+18.68%

S&P 500

Excess Return

-29.72 pts

Relative to SPY

NVZMF Max Drawdown

-27.39%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

NVZMFSPY

Calendar-Year Returns

Uses the longest available daily history for NVZMF and SPY.

YearNVZMFSPYExcessLeader
2026+1.16%+6.71%-5.54 ptsSPY
2025-11.20%+11.19%-22.39 ptsSPY

Financial profile

Novozymes A/S (NVZMF)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$15.0B

-14.8% YoY

FY Net Income

$3.1B

-14.4% YoY

Free Cash Flow

$2.8B

+152.9% YoY

Revenue Growth

-85.5%

EPS Growth

+86.6%

Gross Margin

53.9%

Net Margin

14.0%

Income statement

EUR

Annual
Metric20252024202320222021
Revenue4.2B28.6B17.9B17.6B15.0B
Gross Profit2.2B14.9B9.7B9.6B8.6B
Operating Income883M3.7B4.0B4.6B4.0B
EBITDA1.4B8.1B5.6B5.7B5.1B
Net Income584M2.3B3.0B3.7B3.1B
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

EUR

Point-in-time
Metric20252024202320222021
Cash & Equivalents275M280M1.1B1.0B963M
Total Assets16.3B15.2B28.4B28.0B24.8B
Total Liabilities5.5B4.0B14.0B13.8B12.6B
Shareholder Equity10.9B11.2B14.0B13.8B11.8B
Total Debt3.0B1.8B7.7B919M482M
Net Debt2.7B1.5B6.6B779M-481M

Cash flow positioning

Latest Full Year

Operating Cash Flow

4.1B

+1.4% YoY

Capital Expenditures

1.2B

+57.1% YoY

Free Cash Flow

2.8B

+152.9% YoY

Key ratios

  • Gross Margin

    53.9%

  • Operating Margin

    21.2%

  • Net Margin

    14.0%

  • ROE

    5.4%

  • Debt / Equity

    2.07x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.